CNS Pharmaceuticals, Inc. (CNSP) SEC Filings & Financial Intelligence
CNS Pharmaceuticals, Inc. (CNSP) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CNSP
CIK: 1729427
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
MaloneBailey, LLP
Auditor SinceSince 12/31/2018 12:00:00 AM
Lead Engagement PartnerSteven Vertucci
Audit LocationHouston, Texas, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-02 | 2026-09-30 | FORM 8-K | 0001683168-26-007552 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-25 | — | DEFA14A | 0001683168-26-006724 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-21 | 2026-09-30 | DEFINITIVE NOTICE AND PROXY STATEMENT | 0001683168-26-006660 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-05-18 | 4 Filing | 0001683168-26-006553 | View SEC Doc Filr Page |
| 3 | 2026-08-18 | 2026-05-04 | 3 Filing | 0001683168-26-006551 | View SEC Doc Filr Page |
| 4 | 2026-08-18 | 2026-08-14 | 4 Filing | 0001683168-26-006552 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352973 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | FORM 10-Q FOR JUN 2026 | 0001683168-26-006224 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-02 | FORM 8-K | 0001683168-26-005233 | View SEC Doc Filr Page |
| EFFECT | 2026-05-26 | — | EFFECT Filing | 9999999995-26-001762 | View SEC Doc Filr Page |
| 424B3 | 2026-05-26 | — | 424B3 PROSPECTUS | 0001683168-26-004304 | View SEC Doc Filr Page |
| CORRESP | 2026-05-22 | — | CORRESP Filing | 0001683168-26-004266 | View SEC Doc Filr Page |
| UPLOAD | 2026-05-22 | — | UPLOAD Filing | 0000000000-26-005256 | View SEC Doc Filr Page |
| 4 | 2026-05-20 | 2026-05-18 | 4 Filing | 0001683168-26-004145 | View SEC Doc Filr Page |
| D | 2026-05-19 | — | D Filing | 0001683168-26-004126 | View SEC Doc Filr Page |
| S-3 | 2026-05-19 | — | FORM S-3 REGISTRATION STATEMENT | 0001683168-26-004123 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000935836-26-000277 | View SEC Doc Filr Page |
| 10-Q | 2026-05-14 | 2026-03-31 | FORM 10-Q FOR MAR 2026 | 0001683168-26-003847 | View SEC Doc Filr Page |
| 8-K | 2026-05-04 | 2026-05-04 | FORM 8-K | 0001683168-26-003432 | View SEC Doc Filr Page |
| 10-K/A | 2026-04-30 | 2025-12-31 | AMENDMENT #1 TO FORM 10-K | 0001683168-26-003374 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-17 | — | SCHEDULE 13G Filing | 0001193125-26-161735 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | FORM 10-K FOR DEC 2025 | 0001683168-26-002550 | View SEC Doc Filr Page |
| 8-K | 2026-03-11 | 2026-03-11 | CURRENT REPORT | 0001683168-26-001664 | View SEC Doc Filr Page |
| 4 | 2026-03-04 | 2026-03-02 | 4 Filing | 0001683168-26-001491 | View SEC Doc Filr Page |
| 3 | 2026-03-04 | 2026-03-02 | 3 Filing | 0001683168-26-001490 | View SEC Doc Filr Page |